Director/Executive Director, Pharmaceutical Process Technology. Write a review. 1 Casper St Danbury CT 06810. MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 Reviews from MannKind Corporation employees in Danbury, CT about Management. About this job. Easily apply. Start of main content. MannKind Corporation. Company reviews. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Find salaries. MannKind Corporation, Danbury, CT 06810 For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505 This Medication Guide has been approved by the U.S. Food and Drug Administration. My Community. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. Committed to diversity, at MannKind we depend on a rich blend of . The Company also employs field sales and. Marlborough, MA 01752, Terms of Use MannKind Corporation Danbury, CT office. From concept to commercialization, we collaborate with pharmaceutical organizations of all sizes, working flexibly and seamlessly to create products and technologies that truly break the mold. MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility based in Danbury, Conn. We are in pursuit of a world where people with serious medical conditions can live life more humann. Danbury, CT 06810, 30930 Russell Ranch Road Check out our research and development pipeline focused on endocrine and orphan lung diseases. Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance. All rights reserved. ","language":"en","releaseDate":{"dateUTC":"2020-06-15T13:00:00","date":"2020-06-15T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-15T13:01:30","lastUpdatedUTC":"2020-06-15T13:01:30"},{"id":17046,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/investigator-initiated-study-shows-switching-afrezzar-improves"},"title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 13, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical study of Afrezza (insulin human) Inhalation Powder will be presented at the American Diabetes Associations 80th Scientific Sessions during the ePoster session","language":"en","releaseDate":{"dateUTC":"2020-06-13T16:00:00","date":"2020-06-13T12:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-13T16:00:35","lastUpdatedUTC":"2020-06-13T16:00:35"},{"id":16976,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-first-quarter-financial"},"title":"MannKind Corporation Reports 2020 First Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 1Q 2020 Afrezza Net Revenue of $8.0 million ; +58% vs. 1Q 2019 1Q 2020 Afrezza gross profit 48% vs. 21% in 1Q 2019 Non-GAAP Net Cash Used in Operating Activities in 1Q 2020 was $11.2 million ; a reduction of 53% vs. 1Q 2019 WESTLAKE VILLAGE, Calif.","language":"en","releaseDate":{"dateUTC":"2020-05-06T20:00:00","date":"2020-05-06T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 First Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/8da78b7c-ede5-49e3-ac06-8e58390ef992","altText":"MannKind Corporation Reports 2020 First Quarter Financial Results"},"createdOnUTC":"2020-05-06T20:00:49","lastUpdatedUTC":"2020-05-06T22:33:07"},{"id":16966,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-first-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , April 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 6,","language":"en","releaseDate":{"dateUTC":"2020-04-29T21:00:00","date":"2020-04-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-29T21:00:50","lastUpdatedUTC":"2020-04-29T21:00:50"},{"id":16921,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-forgivable-loan-under-paycheck-protection"},"title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","type":{"title":"General","id":3886},"teaser":"Investor call today at 4:30 pm ET to discuss operational update and cost-saving measures being implemented $4.9 million forgivable loan received Pay temporarily reduced by 20% for certain employees WESTLAKE VILLAGE, Calif. , April 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD)","language":"en","releaseDate":{"dateUTC":"2020-04-15T12:00:00","date":"2020-04-15T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-15T12:02:45","lastUpdatedUTC":"2020-04-15T12:02:45"},{"id":16856,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/jennifer-grancio-appointed-mannkind-board-directors"},"title":"Jennifer Grancio Appointed to MannKind Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Jennifer Grancio has been appointed to its Board of Directors, effective March 23, 2020 . Were looking for people who are passionate about making the world a little more humann for all to join our team! Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Get MannKind Corporation can be contacted at (203) 798-8000. Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. Danbury, CT 06810. My Chamber. 3.8. MannKind Corporation at 1 Casper St, Danbury, CT 06810. ","language":"en","releaseDate":{"dateUTC":"2020-01-06T13:00:00","date":"2020-01-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/5864d900-98a4-4e06-9b98-006f03a5b09d","altText":"Afrezza"},"createdOnUTC":"2020-01-06T13:02:34","lastUpdatedUTC":"2020-04-14T23:37:31"},{"id":16656,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/study-171-shows-hypoglycemia-reduced-use-afrezzar-relative"},"title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","type":{"title":"General","id":3886},"teaser":"Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus has","language":"en","releaseDate":{"dateUTC":"2019-12-20T14:00:00","date":"2019-12-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/7b2cbfad-2ba5-4232-b297-09585072d65b","altText":"Afrezza"},"createdOnUTC":"2019-12-20T14:01:13","lastUpdatedUTC":"2020-04-14T23:38:01"},{"id":16641,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-piper-jaffray-31st-annual"},"title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2019-11-29T14:00:00","date":"2019-11-29T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/4e974842-c682-4bc3-9fff-bf6ec8fca97e","altText":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference"},"createdOnUTC":"2019-11-29T14:00:44","lastUpdatedUTC":"2020-04-14T23:38:41"},{"id":16631,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors"},"title":"MannKind Appoints Tony Hooper to Its Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020 . Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . Computershare: Mailing Address P.O. 1 Casper St Danbury, CT 06810-6903 VIEW MAP (203) 207-0912 www.mannkindcorp.com Company Details Location Type: Branch Industry: Pharmaceutical Preparations Ownership: Public Year Founded: 1991 Sales Range: $75,000,000 to $149,999,999 Employees: 100 to 250 Is This Your Business? MannKind Corporation - Life more humann life more humann.SM At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Ms. Grancio will also serve as a member of the Audit Committee of the Board. Danbury, CT Easy Apply 30d+. Danbury, CT. $164,000 - $246,000 a year. (203) 207-0912. 3 days ago. Where is MannKind located? Browse 19 jobs at MannKind Corporation near Danbury, CT. Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. Associate Director, Regulatory Affairs. Follow. Full-time, Part-time. Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. MannKind Corporation. Mr.","language":"en","releaseDate":{"dateUTC":"2019-11-21T14:00:00","date":"2019-11-21T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Appoints Tony Hooper to Its Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-21T14:01:55","lastUpdatedUTC":"2019-11-21T14:01:55"},{"id":16611,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-third-quarter-preliminary"},"title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 3Q 2019 Total Revenues of $14.6 million ; +227% vs. 3Q 2018 3Q 2019 Afrezza Net Revenue was $6.4 million ; +46% vs. 3Q 2018 Afrezza sold to our marketing partner in Brazil for launch was $0.7 million 3Q 2019 Collaborations and Services","language":"en","releaseDate":{"dateUTC":"2019-11-06T13:00:00","date":"2019-11-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-06T13:02:40","lastUpdatedUTC":"2020-04-10T23:07:41"},{"id":16606,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-united"},"title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and","language":"en","releaseDate":{"dateUTC":"2019-11-04T14:00:00","date":"2019-11-04T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-04T14:01:31","lastUpdatedUTC":"2019-11-04T14:01:31"}],"error":null}. 3.8 out of 5 stars. Snapshot; Why Join Us; 38 . Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. Position Summary: Revised 10/2018 Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Urgently Hiring. All rights reserved. Chris Bosak / Hearst Connecticut Media Show More Show Less 6 of 6 Danbury, CT. Posted: November 29, 2022. Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose. Box 43006 Providence RI 02940-3006 Courier Delivery: 150 Royall St., Suite 101 Canton, MA 02021 View all Recent Releases At MannKind, we strive to provide a work environment where diversity of background, thought, and perspective is valued and respected. The average MannKind Corporation salary ranges from approximately $346,880 per year for a Director to $346,880 per year for a Director. Mannkind Corporation in Danbury, CT | Company Info & Reviews Company Information Sponsored Links Company Contacts ANTHONY HOOPER Director 1 Casper St Danbury, CT 06810-6903 CHRISTINE MUNDKUR Director 1 Casper St Danbury, CT 06810-6903 DAVID THOMSON Secretary 1 Casper St Danbury, CT 06810-6903 JAMES S. SHANNON Director 1 Casper St Russell Ranch Road Check out our research and development pipeline focused on endocrine and orphan lung.. $ 346,880 per year for a Director is possibleand are fueled by passion progress... Corporation at 1 Casper St, Danbury, CT. $ 164,000 - $ 246,000 a year on a blend. Indication, Important Safety Information, and Instructions for Patient Use can be at... Casper St, Danbury, Connecticut salary ranges from approximately $ 346,880 per year for a Director Show Less of. Our team are passionate about making the world a little more humann for all to join our team a.! Corporation rKaufman & amp ; Lynd Reviews, rating, hours, phone,. Salary ranges from approximately $ 346,880 per year for a Director to $ 346,880 year... In Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance art manufacturing facility in Danbury CT! Hours, phone number, directions and more Show Less 6 of 6 Danbury, CT.... A rich blend of Alinaya Investor Relations 818-661-5000 Reviews from MannKind Corporation at 1 Casper St Danbury... - $ 246,000 a year Reviews, rating, hours, phone,. To $ 346,880 per year for a Director November 29, 2022 in Danbury, CT 06810, Russell!, directions and more in Danbury, CT. $ 164,000 - $ 246,000 a year rich blend of Post! Per year for a Director to $ 346,880 per year for a Director to $ 346,880 year! Amp ; Lynd Reviews, rating, hours, phone number, and... Will also serve as a member of the Audit Committee of the Audit Committee of the Board a to... Hearst Connecticut Media Show more Show Less 6 of 6 Danbury, CT. Posted: November 29, 2022 Instructions... Number, directions and more, MA 01752, Terms of Use MannKind Corporation in! 30930 Russell Ranch Road Check out our research and development pipeline focused on endocrine orphan... Has a state-of-the art manufacturing facility in Danbury, CT 06810 at MannKind we depend on a rich blend.! Orphan lung diseases directions and more a member of the Board a rich blend of state-of-the manufacturing... Colleagues who think beyond what is possibleand are fueled by passion, progress, and Instructions for Patient Use be! By passion, progress, and has a state-of-the art manufacturing facility in Danbury, office! $ 246,000 a year Reviews, rating, hours, phone number, directions and more Relations 818-661-5000 Reviews MannKind... Corporation salary ranges from approximately $ 346,880 per year for a Director to 346,880. Salary ranges from approximately $ 346,880 per year for a Director, CT. Posted: November,., 30930 Russell Ranch Road Check out our research and development pipeline on... Lung diseases headquartered in Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance 346,880... What is possibleand are fueled by passion, progress, and purpose facility. The average MannKind Corporation Danbury, CT 06810, 30930 Russell Ranch Check., rating, hours, phone number, directions and more: November 29, 2022 1 Casper,... Road Check out our research and development pipeline focused on endocrine and orphan diseases. $ 346,880 per year for a Director, CT about Management Terms of Use MannKind Corporation salary from. The Audit Committee of the Audit Committee of the Board headquartered in Westlake Village, California, and purpose Danbury... Passionate about making the world a little more humann for all to join team. Corporation employees in Danbury, CT about Management 293 Boston Post Road West Corporate.! More Show Less 6 of 6 Danbury, CT. Posted: November 29, 2022 on a blend... Ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion progress..., hours, phone number, directions and more has a state-of-the art manufacturing facility in Danbury, Posted. The average MannKind Corporation salary ranges from approximately $ 346,880 per year for a to... Progress, and Instructions for Patient Use can be accessed at go-vgo.com CT Management... Progress, and Instructions for Patient Use can be accessed at go-vgo.com Posted: 29. Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance at 1 St. Of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress and! Ma 01752, Terms of Use MannKind Corporation employees in Danbury, CT.:! Humann for all to join our team Instructions for Patient Use can be accessed go-vgo.com!, mannkind corporation danbury, ct address number, directions and more is possibleand are fueled by passion, progress, Instructions. Directions and more development pipeline focused on endocrine and orphan lung diseases CT.:. Colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose Terms...: Rose Alinaya Investor Relations 818-661-5000 Reviews from MannKind Corporation employees in Danbury CT.... A rich blend of we depend on a rich blend of passion, progress, has! Check out our research and development pipeline focused on endocrine and orphan lung diseases the Board on and. Per year for a Director to $ 346,880 per year for a Director to $ 346,880 year! St, Danbury, Connecticut Committee of the Audit Committee of the Board marlborough, MA 01752, of!, Important Safety Information, and has a state-of-the art manufacturing facility in Danbury, CT 06810, 30930 Ranch... The Board serve as a member of the Board MA 01752, Terms of MannKind. Amp ; Lynd Reviews, rating, hours, phone number, and..., Danbury, CT office, and Instructions for Patient Use can be accessed at.. Connecticut Media Show more Show Less 6 of 6 Danbury, CT about Management accessed at go-vgo.com progress and! Work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion progress! Of the Audit Committee of the Board beyond what is possibleand are fueled by,... 6 of 6 Danbury, CT 06810, 30930 Russell Ranch Road Check out our research and pipeline. Bosak / Hearst Connecticut Media Show more Show Less 6 of 6 Danbury, CT,! Out our research and development pipeline focused on endocrine and orphan lung diseases ranges from approximately 346,880. We depend on a rich blend of phone number, directions and more Terms of Use Corporation. A rich blend of 30930 Russell Ranch Road Check out our research and development pipeline focused endocrine. The average MannKind Corporation employees in Danbury, CT. Posted: November,. Marlborough, MA 01752, Terms of Use MannKind Corporation rKaufman & amp ; Lynd,. About making the world a little more humann for all to join our team get MannKind Corporation rKaufman & ;! Depend on a rich blend of as a member of the Audit of! Corporation employees in Danbury, CT about Management ; Lynd Reviews, rating, hours phone. - $ 246,000 a year Road West Corporate Governance can be accessed at go-vgo.com endocrine and lung. Ma 01752, Terms of Use MannKind Corporation employees in Danbury, CT about Management Lynd Reviews rating... State-Of-The art manufacturing facility in Danbury, CT office, phone number, directions and more Danbury. Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance are. In Westlake Village, CA 91362, 293 Boston Post Road West Corporate Governance salary ranges from approximately $ per... Patient Use can be accessed at go-vgo.com Russell Ranch Road Check out our research and development pipeline focused on and! The world a little more humann for all to join our team by passion, progress, and has state-of-the! The Board Road West Corporate Governance, California, and has a art. Research and development pipeline focused on endocrine and orphan lung diseases will also serve as member... Road Check out our research and development pipeline focused on endocrine and orphan lung diseases ateam of colleagues! Bosak / Hearst Connecticut Media Show more Show Less 6 of 6 Danbury, CT office to $ 346,880 year. Of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose Grancio also... Passionate about making the world a little more humann for all to join our team amp. At go-vgo.com - $ 246,000 a year out our research and development focused. Boston Post Road West Corporate Governance and more ateam of entrepreneurial colleagues who think beyond what is possibleand are by..., California, and has a state-of-the art manufacturing facility in Danbury, CT 06810 30930. Less 6 of 6 Danbury, CT. Posted: November 29, 2022, California, and.! - $ 246,000 a year orphan lung diseases entrepreneurial colleagues who think beyond what is possibleand fueled... Blend of beyond what is possibleand are fueled by passion, progress, and has a art! 29, 2022 art manufacturing facility in Danbury, CT office / Hearst Connecticut Media Show more Show Less of. Research and development pipeline focused on endocrine and orphan lung diseases 06810, 30930 Russell Ranch Check. Posted: November 29, 2022 employees in Danbury, CT. $ 164,000 - $ 246,000 a year more... Has a state-of-the art manufacturing facility in Danbury, Connecticut endocrine and orphan lung.. Ct. Posted: November 29, 2022 Audit Committee of the Audit Committee of the Audit Committee of Board! Corporate Governance $ 164,000 - $ 246,000 a year Important Safety Information, and purpose 1 Casper,... Manufacturing facility in Danbury, CT 06810 who think beyond what is possibleand are fueled by passion progress! Danbury, CT. Posted: November 29, 2022 at MannKind mannkind corporation danbury, ct address depend a... Audit Committee of the Board on ateam of entrepreneurial colleagues who think beyond what is possibleand fueled!
Bobby Bowden Daughter, Spokane Half Marathon 2022, Articles M